KRRO · Company research

Korro Bio, Inc. (KRRO): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

18records availableHealthcare

Stock News & Events data

Database-backed records only

18 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Precision Trading with Frequency Therapeutics Inc. (KRRO) Risk Zones - Stock Traders DailyPrecision Trading with Frequency Therapeutics Inc. (KRRO) Risk Zones Stock Traders DailyView source ↗Stock Traders DailyOct 16, 2026neutral00.6
Two new hires can earn the right to buy Korro Bio shares over four years. - Stock TitanTwo new hires can earn the right to buy Korro Bio shares over four years. Stock TitanView source ↗Stock TitanOct 16, 2026neutral00.6
KRRO Oct 2026 20.000 call (KRRO261016C00020000) Stock Price, News, Quote & History - Yahoo! Finance CanadaKRRO Oct 2026 20.000 call (KRRO261016C00020000) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 15, 2026neutral00.6
Korro Bio, Inc. (NASDAQ: KRRO) Share Price, KRRO Stock News, KRRO Share Price & Updates - KalkineKorro Bio, Inc. (NASDAQ: KRRO) Share Price, KRRO Stock News, KRRO Share Price & Updates KalkineView source ↗KalkineOct 15, 2026neutral00.6
Patients with rare disorders are expected to be dosed in 2027, after healthy volunteers got the first dose. - Stock TitanPatients with rare disorders are expected to be dosed in 2027, after healthy volunteers got the first dose. Stock TitanView source ↗Stock TitanOct 5, 2026neutral00.6
Korro Bio Inc (KRRO-Q) Stock Price and News - The Globe and MailKorro Bio Inc (KRRO-Q) Stock Price and News The Globe and MailView source ↗The Globe and MailOct 1, 2026neutral00.6
$KRRO stock is down 13% today. Here's what we see in our data. - Quiver Quantitative$KRRO stock is down 13% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeSep 17, 2026neutral00.6
Three new hires get options to buy 5,000 Korro Bio shares - Stock TitanThree new hires get options to buy 5,000 Korro Bio shares Stock TitanView source ↗Stock TitanSep 11, 2026neutral00.6
Korro Bio, Inc. (KRRO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo FinanceKorro Bio, Inc. (KRRO) Upgraded to Buy: What Does It Mean for the Stock? Yahoo FinanceView source ↗Yahoo FinanceJul 8, 2026neutral00.6
KRRO Forecast — Price Target — Prediction for 2027 - TradingViewKRRO Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
Korro Bio, Inc. (KRRO) Soars 17.6%: Is Further Upside Left in the Stock? - Yahoo FinanceKorro Bio, Inc. (KRRO) Soars 17.6%: Is Further Upside Left in the Stock? Yahoo FinanceView source ↗Yahoo FinanceJun 19, 2026neutral00.6
Korro Bio: RNA Editor Plots Way Back After AATD Study Fail - I'm Holding (NASDAQ:KRRO) - Seeking AlphaKorro Bio: RNA Editor Plots Way Back After AATD Study Fail - I'm Holding (NASDAQ:KRRO) Seeking AlphaView source ↗Seeking AlphaJun 15, 2026neutral00.6
$KRRO stock is down 12% today. Here's what we see in our data. - Quiver Quantitative$KRRO stock is down 12% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeJun 2, 2026neutral00.6
KRRO Shares Jump 13% On Analyst Upgrades — What’s Driving The Optimism? - StocktwitsKRRO Shares Jump 13% On Analyst Upgrades — What’s Driving The Optimism? StocktwitsView source ↗StocktwitsJan 29, 2026neutral00.6
StockWatch: Korro Craters 81% on Data; Patient Death Sours Analysts on Intellia - Genetic Engineering and Biotechnology NewsStockWatch: Korro Craters 81% on Data; Patient Death Sours Analysts on Intellia Genetic Engineering and Biotechnology NewsView source ↗Genetic Engineering and Biotechnology NewsNov 16, 2025neutral00.6
Why Korro Bio (KRRO) Is Down 80.0% After Restructuring, Clinical Trial Miss, and CMO Resignation - Simply Wall StreetWhy Korro Bio (KRRO) Is Down 80.0% After Restructuring, Clinical Trial Miss, and CMO Resignation Simply Wall StreetView source ↗Simply Wall StreetNov 14, 2025neutral00.6
Korro Suffers Cacophony of Bad News as Lead Candidate Fails, Novo Pauses RNA Deal - BioSpaceKorro Suffers Cacophony of Bad News as Lead Candidate Fails, Novo Pauses RNA Deal BioSpaceView source ↗BioSpaceNov 13, 2025neutral00.6
Korro Bio stock crashes as it cuts 34% of workforce due to clinical trial fail - The Business JournalsKorro Bio stock crashes as it cuts 34% of workforce due to clinical trial fail The Business JournalsView source ↗The Business JournalsNov 13, 2025neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.